Immediate Versus Delayed Breast Reconstruction: Integrating Oncologic Safety, Adjuvant Therapy Considerations, and...

Breast reconstruction has become an integral component of modern breast cancer management, aiming to restore body image and improve the quality of life following mastectomy. The optimal timing of reconstruction remains controversial, particularly in the context of adjuvant therapies such as radiotherapy. The aim of this review is to evaluate current evidence comparing immediate with delayed breast reconstruction, focusing on oncologic safety, interaction with adjuvant therapy, complication profiles, and aesthetic outcomes. A narrative review of the literature was performed, incorporating data from meta-analyses, prospective cohort studies, and multicenter trials assessing outcomes of immediate and delayed breast reconstruction. Immediate breast reconstruction is associated with improved aesthetic outcomes and reduced psychosocial distress while maintaining oncologic safety in appropriately selected patients. Evidence suggests that immediate reconstruction does not increase recurrence rates or negatively affect survival outcomes. However, higher complication rates may be observed, particularly in patients requiring postmastectomy radiotherapy. Delayed reconstruction provides greater flexibility in oncologic management and may reduce complication risk in selected patients, although it is often associated with less favorable aesthetic outcomes. Hybrid approaches such as delayed-immediate reconstruction have emerged to balance these competing considerations. The decision between immediate and delayed breast reconstruction should be individualized within a multidisciplinary framework. The integration of oncologic factors, anticipated adjuvant therapy, and patient preferences is essential to optimize both clinical and aesthetic outcomes.